Apellis Pharmaceuticals Inc [APLS] stock Upgrade by Jefferies analyst, price target now $80
Apellis Pharmaceuticals Inc [NASDAQ: APLS] loss -10.06% or -4.91 points to close at $43.90 with a heavy trading volume of 4517944 shares. The daily chart for APLS points out that the company has recorded -6.26% loss over the past six months. If we look at